Over three decades have passed since the first report on the expression of CA125 by
ovarian tumors. Since that time our understanding of ovarian cancer biology has changed …

Ovarian cancer is a lethal gynecologic malignancy with greater than 70% of women
presenting with advanced stage disease. Despite new treatments, long term outcomes have …

Background: Securing a diagnosis of ovarian cancer and establishing means to predict
outcomes to therapeutics remain formidable clinical challenges. Early diagnosis is …

The aim of this study is to evaluate the diagnostic performance of human epididymis protein
4 (HE4), cancer antigen 125 (Ca125) and the risk of ovarian malignancy algorithm (ROMA) …

AIM To determine the association between the distribution of gynecologic oncologist (GO)
and population-based ovarian cancer death rates. MATERIALS AND METHODS Data on …

STUDY QUESTION What are the frequency of, and the prognosis for, ovarian malignancies
among patients who have undergone laparoscopic surgery for an adnexal mass …

Background Accumulating evidence suggests that many ovarian cancers represent
metastases from occult fallopian tube carcinomas or tumors arising within ovarian …

ABSTRACT BACKGROUND Studies have shown a mismatch between published cancer
screening and genetic counseling referral recommendations and physician-reported …

В статье представлены классификация, клиническая картина и распространенность
злокачественных опухолей яичников. Раскрыты вопросы дифференциальной …

Введение. Ранняя диагностика рака яичников (РЯ) представляет собой важную
проблему современной онкогинекологии в связи со значительной частотой выявления …